Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 9.86%557K | -212K | 1.5M | -42.86%5.54M | 2.08M | 507K | 23.09%9.7M | 41.87%7.88M | -12.36%5.56M | 6.34M |
| Net profit before non-cash adjustment | 725.34%3.21M | --512K | --863K | -31.76%5.92M | --3.27M | ---513K | 34.39%8.68M | 2.68%6.46M | 127.85%6.29M | --2.76M |
| Total adjustment of non-cash items | -128.57%-194K | ---50K | --360K | -40.30%1.24M | ---106.5K | --679K | 6.14%2.08M | 25.91%1.96M | 76.71%1.56M | --882.05K |
| -Depreciation and amortization | -65.71%131K | --104K | --616K | -10.01%1.53M | --397.1K | --382K | 1.83%1.7M | 15.50%1.67M | 75.41%1.45M | --825.83K |
| -Reversal of impairment losses recognized in profit and loss | 945.00%209K | --107K | --147K | -98.31%5.63K | --55.63K | --20K | 17.69%332.39K | 140.92%282.42K | 1,699.25%117.23K | ---7.33K |
| -Disposal profit | ---513K | ---568K | ---481K | ---254.58K | ---254.58K | --0 | --0 | -5.10%-32K | ---30.45K | --0 |
| -Net exchange gains and losses | ---19K | --315K | --77K | 138,242.73%151.96K | ---192.04K | ---- | 31.25%-110 | 82.72%-160 | -116.31%-926 | --5.68K |
| -Other non-cash items | 97.01%-2K | ---8K | --1K | -509.72%-192.6K | ---112.6K | ---67K | 20.03%47.01K | 61.78%39.16K | -58.17%24.21K | --57.87K |
| Changes in working capital | -820.53%-2.46M | ---674K | --278K | -53.19%-1.62M | ---1.09M | --341K | -96.74%-1.06M | 76.52%-538.25K | -184.98%-2.29M | --2.7M |
| -Change in receivables | 919.48%1.89M | ---2.08M | --1.01M | 56.49%-774.48K | ---1.06M | ---231K | -8,639.02%-1.78M | 99.18%-20.37K | -199.38%-2.5M | --2.51M |
| -Change in inventory | 20.77%-900K | --337K | --539K | 107.14%87.84K | --1.01M | ---1.14M | -60.31%-1.23M | -2,427.81%-767.06K | -92.00%32.95K | --411.74K |
| -Change in payables | -18.97%1.38M | --809K | ---1.16M | -157.18%-1.12M | ---1.22M | --1.71M | 682.92%1.95M | 43.74%249.18K | 175.94%173.35K | ---228.27K |
| -Changes in other current assets | ---4.83M | --261K | ---115K | --179.8K | --179.8K | --0 | --0 | ---- | ---- | ---- |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | -122.59%-601K | -575K | -638K | 22.25%-2.06M | -594.51K | -270K | -120.81%-2.65M | 2.88%-1.2M | 15.62%-1.24M | -1.47M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -118.57%-44K | ---787K | --863K | -50.62%3.48M | --1.48M | --237K | 5.52%7.05M | 54.69%6.68M | -11.38%4.32M | --4.87M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -1,316.00%-708K | ---342K | ---310K | -1,226.18%-790.7K | ---685.7K | ---50K | 78.57%-59.62K | 77.54%-278.26K | 56.46%-1.24M | ---2.85M |
| Net intangibles purchase and sale | --0 | ---- | ---- | ---7.21K | ---208 | --0 | --0 | --0 | --0 | --0 |
| Net investment product transactions | -10,740.00%-532K | ---- | ---- | 202.54%4.48K | ---520 | --5K | ---4.37K | --0 | --0 | --593.23K |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | --0 | ---- | ---- | --0 | ---- | ---- | ---- |
| Dividends received (cash flow from investment activities) | --294K | --142K | --282K | --207.66K | --207.66K | --0 | --0 | ---- | ---- | ---- |
| Interest received (cash flow from investment activities) | -98.65%1K | --5K | --1K | --221.84K | --119.84K | --74K | --0 | --0 | --0 | --8.04K |
| Net changes in other investments | ---- | ---- | ---- | 7,421.22%319.86K | ---- | ---- | ---4.37K | ---- | ---- | ---- |
| Investing cash flow | -3,358.62%-945K | ---195K | ---27K | 31.14%-44.06K | ---39.06K | --29K | 77.00%-63.99K | 77.54%-278.26K | 44.80%-1.24M | ---2.24M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 98.11%-1K | --0 | ---1K | -204.86%-548.08K | ---392.08K | ---53K | -3.17%-179.78K | -63.15%-174.25K | 93.18%-106.81K | ---1.57M |
| Net common stock issuance | ---- | ---- | ---- | 43,036,456.00%43.04M | ---444 | ---- | --100 | --0 | --0 | --0 |
| Increase or decrease of lease financing | 0.00%-16K | ---16K | ---16K | -5.23%-61.88K | ---15.88K | ---16K | -15.25%-58.81K | -198.52%-51.02K | ---17.09K | --0 |
| Issuance fees | ---- | ---- | ---- | ---2.06M | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash dividends paid | ---- | ---- | ---- | -111.91%-4.24M | ---- | ---- | 68.25%-2M | -215.00%-6.3M | ---2M | ---- |
| Interest paid (cash flow from financing activities) | 71.43%-2K | ---2K | ---3K | 51.07%-29.24K | ---7.24K | ---7K | -24.70%-59.75K | -46.02%-47.91K | 59.64%-32.81K | ---81.3K |
| Net other fund-raising expenses | ---- | ---- | ---- | --320K | ---- | ---- | ---- | ---- | ---- | ---- |
| Financing cash flow | -100.04%-19K | ---18K | ---20K | 1,760.37%38.16M | ---4.65M | --42.96M | 65.04%-2.3M | -204.78%-6.57M | -30.89%-2.16M | ---1.65M |
| Net cash flow | ||||||||||
| Beginning cash position | 517.68%47.68M | --48.56M | --47.63M | 323.16%6.14M | --50.6M | --7.72M | -10.49%1.45M | 132.42%1.62M | 345.51%697.24K | ---284K |
| Current changes in cash | -102.33%-1.01M | ---1M | --816K | 787.36%41.6M | ---3.21M | --43.23M | 2,855.84%4.69M | -118.42%-170.1K | -5.90%923.3K | --981.24K |
| Effect of exchange rate changes | 169.19%238K | --111K | --122K | -95,583.64%-105.03K | --238.97K | ---344K | -31.25%110 | --160 | ---- | --0 |
| End cash Position | -7.30%46.91M | --47.68M | --48.56M | 675.93%47.63M | --47.63M | --50.6M | 323.16%6.14M | -10.49%1.45M | 132.42%1.62M | --697.24K |
| Free cash flow | -502.14%-752K | ---1.13M | --553K | -61.61%2.68M | --795.51K | --187K | 9.72%6.99M | 108.92%6.37M | 50.39%3.05M | --2.03M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.